CANNABIS COMPANY ENTERS THE BEVERAGE MARKET

CANNABIS COMPANY ENTERS THE BEVERAGE MARKET

MEDICINAL marijuana player Creso Pharma (ASX: CPH) has announced its entry into the edibles industry, launching two major partnerships with global manufacturing partners.

Creso has entered into a joint venture with Canada's LGC Capital Ltd and the UK's Baltic Beer Company to develop cannabis and hemp derived drinks.

The three companies will create a range of unique cannabis and hemp derived alcoholic and non-alcoholic beverages, allowing Creso to expand its offering into the edible and lifestyle markets.

This announcement marks yet another milestone for the Australian and Switzerland based marijuana company who recently broke into the Chinese market.

Research and development work has already begun into creating these hemp based beverages.

The groups are working on creating a premium craft beer range containing unique mixes mimicking the terpenes of the cannabis plant.

For the uninitiated, terpenes are essential oils found in plants that carry flavour and aroma. The terpenes in the beer will carry the characteristic odour and fragrance of cannabis with the same taste and feel but will not contain THC or CBD.

The first batch of beer will land on shelves in June or July 2018.

The recent legalisation of hemp seed-based food and drink products in Australia have opened the country up to a variety of new and exciting hemp based edibles.

Earlier in the week, one of the ASX's biggest cannabis players, Queensland Bauxite, announced it will release its flagship hemp foods brand to the market early next month.

QBL's subsidiary Medical Cannabis Limited will launch its VitaHemp product range including VitaHemp honey, Hulled Hemp Seeds, Raw Cold Pressed Hemp Seed Oil, Hemp Seed Protein Powder, and Hemp Seed Flour Blends.

Like Creso Pharma, VitaHemp is doubling down on the beverage market, and launching a hemp based milk product designed to replace dairy milk.

John McMullen, CEO of LGC Capital says the cannabis beverage industry will only get bigger and bigger.

"The cannabis infused beverage industry is an emerging and growing industry and we see a lot of potential value in this market," says McMullen.

Shares in Creso Pharma are currently trading up by 5 percent  to $0.06 per share at 12.05pm (AEDT).

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Enjoyed this article?

Don't miss out on the knowledge and insights to be gained from our daily news and features.

Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.

Support independent journalism and stay informed with stories that matter to you.

Subscribe now and get 50% off your first year!

Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

Former AFL boss Gillon McLachlan to lead Tabcorp as new CEO

Former AFL boss Gillon McLachlan to lead Tabcorp as new CEO

After speculation was quashed that he would be joining Racing Victo...

Luxury fashion seller Azura hits profitability as AI plugs data gaps

Luxury fashion seller Azura hits profitability as AI plugs data gaps

An artificial intelligence (AI) overhaul has allowed Azura Fashion ...

“Not our desired outcome”: Telix withdraws from $300m Nasdaq IPO

“Not our desired outcome”: Telix withdraws from $300m Nasdaq IPO

Telix Pharmaceuticals (ASX: TLX), one of the nation’s largest...

CommBank joins new ‘intelligence loop’ to combat SMS phishing scams

CommBank joins new ‘intelligence loop’ to combat SMS phishing scams

In an effort to reduce the number of SMS phishing scam victims...